IV期黑色素瘤长期生存者:多中心横断面研究
该多中心横断面研究于2024年4月至2025年5月在线调查了296例IV期黑色素瘤长期生存者(总生存>5年),发现约40%存在心理困扰和持续性治疗相关不良事件,约23%有经济困难,且持续性不良事件与心理困扰升高显著相关(OR=1.99,p=0.025)。
要点
- 近80%长期生存者曾接受免疫检查点抑制剂,约27%接受靶向治疗
- 约40%报告心理困扰超阈值及持续性治疗相关不良事件
- 持续性不良事件与心理困扰升高显著相关(OR=1.99,p=0.025)
核心结论
- 相当比例长期生存者面临持续性躯体、心理社会及经济挑战,需建立生存者管理项目。
研究设计与样本
- 多中心横断面在线调查,2024年4月15日至2025年5月9日,纳入296例IV期黑色素瘤总生存>5年的长期生存者,来自奥地利、德国和瑞士40个中心。
主要发现
- 约30%有脑转移,近80%曾接受免疫检查点抑制剂,约27%接受靶向治疗。
- 约40%报告心理困扰超阈值,约40%报告持续性治疗相关不良事件。
- 既往放疗或手术者中约30%报告持续性不良事件,脑放疗后认知缺陷和术后淋巴水肿最常见。
- 持续性全身抗肿瘤治疗相关不良事件与心理困扰升高显著相关(OR=1.99,p=0.025)。
- 约23%报告经济困难;≤65岁者62%仍在工作(半数减少工时),44%退休者因黑色素瘤提前退休。
临床怎么用
- 对长期生存者应筛查持续性治疗相关不良事件、心理困扰及经济困难。
- 建议实施包含职业、财务及心理辅导的生存者管理项目。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since the approval of immune checkpoint inhibitors (ICI) and targeted therapies (TT), the number of long-term survivors of metastatic melanoma (LTS) has increased. However, data on their complaints and needs remain limited. OBJECTIVE: To examine the prevalence and spectrum of treatment-related adverse events (TRAEs), psycho-oncological distress, and socioeconomic outcomes in long-term survivors (LTS), to evaluate their association with elevated distress levels, and to determine whether these findings support the implementation of dedicated survivorship programmes. METHODS: Between April 15, 2024, and May 9, 2025. an online survey was conducted among LTS (overall survival >5 years after stage IV diagnosis) to assess potential TRAEs, financial burden, and psychosocial distress. Validated tools and disease-specific questions were used. All skin cancer centers within the German Dermatologic Cooperative Oncology Group (DeCOG) and patient support groups were invited. RESULTS: A total of 296 LTS from 40 centers in Austria, Germany, and Switzerland participated; approximately 30% had brain metastases. Nearly 80% of the patients had received ICI at any time point, and approximately 27% had received TT. Around 40% reported distress levels above the threshold and persistent TRAEs, respectively. Among patients with prior radiotherapy or surgery, about 30% reported persistent TRAEs for either treatment. Cognitive deficits after cerebral radiotherapy and lymph edema after surgery were the most frequently reported complaints. Persistent TRAEs due to systemic anti-tumor therapy were significantly associated with elevated distress values (OR = 1.99, p = 0.025). About 23% of the patients reported financial constraints. At the time of the survey, 62% of patients aged ≤65 years were still working, half with reduced hours and 44% of retirees had retired early due to melanoma. CONCLUSION: A substantial proportion of LTS face persistent physical, psychosocial, and financial challenges. To address these unmet needs, the implementation of survivorship programs with validated screening and integrated vocational, financial, and psychological counseling is essential.
引用
- Reitmajer M, Livingstone E, Schäffeler N, et al. Beyond the Surface of Long-term Survival in Stage IV Melanoma: A Multicenter Cross-sectional Study. Br J Dermatol. 2026. PMID: 42760605. doi:10.1093/bjd/ljag374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。